4DMedical (ASX:4DX) raised AU$8.4 million via its oversubscribed share purchase plan, according to a Tuesday filing with the Australian bourse.
The company exercised its discretion not to scale back the AU$1.4 million in oversubscription.
New shares are priced at AU$0.36 apiece, a 2.5% discount to the five-day volume-weighted average of the company's shares.
More than 23.3 million new shares will be allotted on Tuesday and are expected to start trading on Wednesday.
In total, the company raised AU$13.9 million via an earlier placement and the share purchase plan. This will be used for general working capital amid a push to advance the commercialization of the company's lung diagnostics portfolio and support the Food and Drug Administration approval of its ventilation and perfusion technology, the filing stated.
The respiratory imaging technology company's shares were up over 1% in recent Tuesday trade, earlier hitting their lowest since March 2023.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。